Abstract
Many cancers arise from gene-environment interactions, where susceptible individuals develop cancer after exposure to toxic or mutagenic environmental agents (1). Genetic instability, whether constitutional or induced, has long been suspected to predispose to carcinogenesis. Cytogenetic assays are classical methods for detecting genetic instability, in which chromosome aberrations are used as biomarkers of the effect of exposure to genotoxic agents. The conceptual basis of this approach revolves around the assumption that the extent of genetic damage reflects critical events in the carcinogenic process, such as an impaired ability to remove damaged DNA or failure to correctly rejoin DNA breaks (2). In a prospective study, Sorsa et al. (3) reported that subjects with a high level of chromosomal aberrations appeared to be at an elevated risk for cancer. Bonassi et al. (4) and Hagmar et al. (5), in two independent prospective studies, reported a significant increase in the mortality ratio for all cancers in subjects who had earlier shown elevated levels of chromosomal aberrations in their lymphocytes. Recently, the data from these two studies were pooled and the results indicate that the frequency of chromosome aberrations in peripheral blood lymphocytes is a relevant biomarker for cancer risk in humans, reflecting early biological effects of exposure to genotoxic carcinogens and/or individual susceptibility to cancer (6,7).
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hsu, T. C., Johnston, D. A., Cherry, L. M., Ramikisson, D., Schantz, S. P., Jessup, J. M., et al. (1989) Sensitivity of genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int. J. Cancer 43, 403–409.
Heim, S. and Mitelman, F. (1987) Cancer cytogenetics. Alan R. Liss, New York, NY.
Sorsa, M., Wilbourn, J., and Vainio, H. (1992) Human cytogenetic damage as a predictor of cancer risk, in Mechanisms of Carcinogenesis in Risk Identification (Vainio, H., Magee, P. N., McGregor, D. B., and McMicheal, A. J., eds.), IARC Scientific Publication No. 116. International Agency for Research on Cancer, Lyon, pp. 543–554.
Bonassi, S. and Abbondandolo, A. (1995) Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Cancer Genet. Cytogenet. 79, 133–135.
Hagmar, L., Brogger, A., Hansteen, I. L., Heim, S., Hogstedt, B., Knudsen, L., et al. (1994) Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res. 54(11), 2919–2922.
Hagmar, L., Bonassi, S., Stromberg, U., Brogger, A., Knudsen, L. E., Norppa, H., et al. (1998) Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res. 58(18), 4117–4121.
Bonassi, S., Hagmar, L., Stromberg, U., Montagud, A. H., Tinnerberg, H., Forni, A., et al. (2000) Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res. 60(6), 1619–1625.
Murg, M. N., Schuler, M., and Eastmond, D. A. (1999) Persistence of chromosomal alterations affecting the 1ce-q12 region in a human lymphoblastoid cell line exposed to dieposybutane and mitomycin C. Mutation Res. 446, 193–203
Visakorpi, T., Hyytinen, E., Kalloiniemi, A., Isola, J., and Kalloiniemi, O. P. (1994) Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. Am. J. Pathol. 145, 624–630.
Takahashi, S., Qian, J., Brown, J. A., Alcaraz, A., Bostwick, D. G., Liber, M. M., and Jenkins, R. B. (1994) Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res. 54, 3574–3579.
Chang, S. S. and Mar, F. F. (1997) Emerging molecular cytogenetic technologies. Cytobios. 90(360), 7–22.
Pinkel, D., Straume, T., and Gray, J. W. (1986) Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc. Natl. Acad. Sci. USA 83(9), 2934–2938.
Eastmond, D. A. and Pinkel, D. (1990) Detection of aneuploidy and aneuploidy-inducing agents in human lymphocytes using fluorescence in situ hybridization with chromosome-specific DNA probes. Mutat. Res. 234(5), 303–318.
Eastmond, D. A., Rupa, D. S., and Hasegawa, L. S. (1994) Detection of hyperdiploidy and chromosome breakage in interphase human lymphocytes following exposure to the benzene metabolite hydroquinone using multicolor fluorescence in situ hybridization with DNA probes. Mutat. Res. 32, 9–20.
Poddighe, P. J., Moesker, O., Smeets, D., Awwad, B. H., Ramaekers, F. C., and Hopman, A. H. (1991) Interphase cytogenetics of hematological cancer: comparison of classical karyotyping and in situ hybridization using a panel of eleven chromosome specific DNA probes. Cancer Res. 51(7), 1959–1967.
Kadam, P., Umerani, A., Srivastava, A., Masterson, M., Lampkin, B., and Raza, A. (1991) Combination of classical and interphase cytogenetics to investigate the biology of myeloid disorders: detection of masked monosomy 7 in AML. Leuk. Res. 17(4), 365–374.
Kibbelaar, R. E., Kok, F., Dreef, E. J., Kleiverda, J. K., Cornelisse, C. J., Raap, A. K., and Kluin, P. M. (1993) Statistical methods in interphase cytogenetics: an experimental approach. Cytometry 14(7), 716–724.
Abdel-Rahman, S. Z., Salama, S. A., Au, W. W., and Hamada, F. A. (2000) Role of polymorphic CYP2E1 and CYP2D6 genes in NNK-induced chromosome aberrations in cultured human lymphocytes. Pharmacogenetics 10(3), 239–249.
Abdel-Rahman, S. Z. and El-Zein, R. A. (2000) The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett. 159(1), 63–71.
El-Zein, R., Bondy, M. L., Wang, L. E., de Andrade, M., Sigurdson, A. J., Bruner, J. M., et al. (2001) Risk assessment for developing gliomas: a comparison of two cytogenetic approaches. Mutat. Res. 490(1), 35–44.
Obe, G. and Herha, J. (1987) Chromosomal aberrations in heavy smokers. Hum. Genet. 41, 259–263.
Vijayalaxmi and Evans, H. J. (1982) In vivo and in vitro effects of cigarette smoke on chromosomal damage and sister chromatid exchange in human peripheral blood lymphocytes. Mutat. Res. 92, 321–332.
Littlefield, L. G. and Joiner, A. A. (1986) Analysis of chromosome aberrations in lymphocytes of long-term heavy smokers. Mutat. Res. 170, 145–150.
Sinues, B., Izquierdo, M., and Perez, V. (1990) Chromosome aberrations and urinary thioethers in smoker. sMutat. Res. 240, 289–293.
Tawn, E. J. and Cartmell, C. L. (1989) The effect of smoking on the frequencies of asymmetrical and symmetrical chromosome exchanges in human lymphocytes. Mutat. Res. 224, 151–156.
van Diemen, P. C., Maasadam, D., Darroudi, F., and Natarajan, A. T. (1995) Influence of smoking habits on the frequencies of structural and numerical chromosomal aberrations in human peripheral blood lymphocytes using the fluorescence in situ hybridization (FISH) technique. Mutagenesis 10, 487–495.
Brinkworth, M. H., Yardley-Jones, A., Edwards, A. J., Hughes, J. A., and Anderson, D. (1992) A comparison of smokers and nonsmokers with respect to oncogene products and cytogenetic parameters. J. Occup. Med. 34, 1181–1188.
Rupa, D. S., Hasegawa, L. S., and Eastmond, D. A. (1995) Detection of chromosomal breakage in the 1cen-1q12 region of interphase human lymphocytes using multicolorfluorescence in situ hybridization with tandem DNA probes. Cancer Res. 55, 640–645.
Conforti-Froes, N., El-Zein, R., Abdel-Rahman, S. Z., Zwischenberger, J. B., and Au, W. W. (1997) Predisposing genes and increased chromosome aberrations in lung cancer cigarette smokers. Mutat. Res. 379, 53–59.
Larizza, L., Doneda, L., Ginelli, E., and Fossati, E. (1988) C-heterochromatin variation and transposition in tumor progression, in Cancer Metastasis: Biological and Biochemical Mechanisms and Clinical Aspects (Prodi, G., et al., eds.), Plenum Publishing Corp., New York, pp. 309–318.
Doneda, L., Ginelli, E., Agresti, A., and Larizza, L. (1989) In situ hybridization analysis of interstitial C-heterochromatin in marker chromosomes of two human melanomas. Cancer Res. 49, 433–438.
Smith, L. E. and Grosovsky, A. J. (1993) Genetic instability on chromosome 16 in a human B lymphoblastoid cell line. Somat. Cell. Mol. Genet. 19, 515–527.
Grosovsky, A. J., Parks, K., Giver, C. R., and Nelson, S. L. (1996) Clonal analysis of delayed karyotypic abnormalities and gene mutations in radiation-induced genetic instability. Mol. Cell. Biol. 16, 6252–6262.
El-Zein, R., Abdel-Rahman, S. Z., Conforti-Froes, N., Alpard, S. K., and Zwischenberger, J. B. (2000) Chromosome aberrations as a predictor of clinical outcome for smoking associated lung cancer. Cancer Lett. 158(1), 65–71.
Abdel-Rahman, S. Z., El-Zein, R. A., Zwischenberger, J. B., and Au, W. W. (1998) Association of the NAT1 22C7 10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers. Mutat. Res. 398(1–2), 43–54.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
El-Zein, R.A., Abdel-Rahman, S.Z. (2003). Detection of Chromosomal Aberrations in Lung Tissue and Peripheral Blood Lymphocytes Using Interphase Fluorescence In Situ Hybridization (FISH). In: Driscoll, B. (eds) Lung Cancer. Methods in Molecular Medicine™, vol 75. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-324-0:145
Download citation
DOI: https://doi.org/10.1385/1-59259-324-0:145
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-0-89603-920-9
Online ISBN: 978-1-59259-324-8
eBook Packages: Springer Protocols